Concepedia

Tomislav Karoli

TK

Statistics

Publications

19

Citations

1K

H-Index

16

Active since

2000

Affiliations

The University of Queensland(Current)

Ligand Pharmaceuticals (United Kingdom)

University of California San Diego

GlaxoSmithKline (United Kingdom)

Heidelberg University

Tomislav Karoli is an author at The University of Queensland specializing in pharmacology, medicinal chemistry, and drug discovery.

ORCID

Publications per year

2000–2018

19

Publications

19

Protein-inspired antibiotics active against vancomycin- and daptomycin-resistant bacteria

Mark A. T. Blaskovich, Karl A. Hansford, Yujing Gong et al. · Nature Communications · 2017 · 148 citations · Full text

, , +17

Discovery of PG545: A Highly Potent and Simultaneous Inhibitor of Angiogenesis, Tumor Growth, and Metastasis

Vito Ferro, Ligong Liu, Ken D. Johnstone et al. · Journal of Medicinal Chemistry · 2012 · 131 citations · Full text

, , +16

Synthesis, Biological Activity, and Preliminary Pharmacokinetic Evaluation of Analogues of a Phosphosulfomannan Angiogenesis Inhibitor (PI-88)

Tomislav Karoli, Ligong Liu, Jon K. Fairweather et al. · Journal of Medicinal Chemistry · 2005 · 86 citations · Full text

, , +15

Analogues of SB-203207 as inhibitors of tRNA synthetases

Martin G. Banwell, Curtis F. Crasto, Christopher J. Easton et al. · Bioorganic & Medicinal Chemistry Letters · 2000 · 80 citations · Full text

, , +10

Synthesis and Biological Evaluation of Polysulfated Oligosaccharide Glycosides as Inhibitors of Angiogenesis and Tumor Growth

Ken D. Johnstone, Tomislav Karoli, Ligong Liu et al. · Journal of Medicinal Chemistry · 2010 · 72 citations · Full text

, , +17

1–5 of 19